Septal flash correction with His-Purkinje pacing predicts echocardiographic response in resynchronization therapy.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
Mar 2022
Historique:
revised: 27 12 2021
received: 19 09 2021
accepted: 02 01 2022
pubmed: 12 1 2022
medline: 22 4 2022
entrez: 11 1 2022
Statut: ppublish

Résumé

His-Purkinje conduction system pacing (HPCSP) has been proposed as an alternative to Cardiac Resynchronization Therapy (CRT); however, predictors of echocardiographic response have not been described in this population. Septal flash (SF), a fast contraction and relaxation of the septum, is a marker of intraventricular dyssynchrony. The study aimed to analyze whether HPCSP corrects SF in patients with CRT indication, and if correction of SF predicts echocardiographic response. This retrospective analysis of prospectively collected data included 30 patients. Left ventricular ejection fraction (LVEF) was measured with echocardiography at baseline and at 6-month follow-up. Echocardiographic response was defined as increase in five points in LVEF. HPCSP shortened QRS duration by 48 ± 21 ms and SF was significantly decreased (baseline 3.6 ± 2.2 mm vs. HPCSP 1.5 ± 1.5 mm p < .0001). At 6-month follow-up, mean LVEF improvement was 8.6% ± 8.7% and 64% of patients were responders. There was a significant correlation between SF correction and increased LVEF (r = .61, p = .004). A correction of ≥1.5 mm (baseline SF - paced SF) had a sensitivity of 81% and 80% specificity to predict echocardiographic response (area under the curve 0.856, p = .019). HPCSP improves intraventricular dyssynchrony and results in 64% echocardiographic responders at 6-month follow-up. Dyssynchrony improvement with SF correction may predict echocardiographic response at 6-month follow-up.

Sections du résumé

BACKGROUND BACKGROUND
His-Purkinje conduction system pacing (HPCSP) has been proposed as an alternative to Cardiac Resynchronization Therapy (CRT); however, predictors of echocardiographic response have not been described in this population. Septal flash (SF), a fast contraction and relaxation of the septum, is a marker of intraventricular dyssynchrony.
METHODS METHODS
The study aimed to analyze whether HPCSP corrects SF in patients with CRT indication, and if correction of SF predicts echocardiographic response. This retrospective analysis of prospectively collected data included 30 patients. Left ventricular ejection fraction (LVEF) was measured with echocardiography at baseline and at 6-month follow-up. Echocardiographic response was defined as increase in five points in LVEF.
RESULTS RESULTS
HPCSP shortened QRS duration by 48 ± 21 ms and SF was significantly decreased (baseline 3.6 ± 2.2 mm vs. HPCSP 1.5 ± 1.5 mm p < .0001). At 6-month follow-up, mean LVEF improvement was 8.6% ± 8.7% and 64% of patients were responders. There was a significant correlation between SF correction and increased LVEF (r = .61, p = .004). A correction of ≥1.5 mm (baseline SF - paced SF) had a sensitivity of 81% and 80% specificity to predict echocardiographic response (area under the curve 0.856, p = .019).
CONCLUSION CONCLUSIONS
HPCSP improves intraventricular dyssynchrony and results in 64% echocardiographic responders at 6-month follow-up. Dyssynchrony improvement with SF correction may predict echocardiographic response at 6-month follow-up.

Identifiants

pubmed: 35015308
doi: 10.1111/pace.14445
pmc: PMC9303224
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

374-383

Subventions

Organisme : "Grant of the Catalan Society of Cardiology, 2019": Resynchronization therapy with hisian pacing
Organisme : Research Grant Josep Font 2019, Hospital Clínic de Barcelona

Informations de copyright

© 2022 The Authors. Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.

Références

Heart Rhythm. 2019 Dec;16(12):1791-1796
pubmed: 31233818
Circulation. 1973 Aug;48(2):272-80
pubmed: 4726207
Pacing Clin Electrophysiol. 2022 Mar;45(3):374-383
pubmed: 35015308
Circulation. 2019 Aug 20;140(8):e382-e482
pubmed: 30586772
JACC Clin Electrophysiol. 2021 Sep;7(9):1166-1177
pubmed: 33933414
Heart Rhythm. 2016 Jun;13(6):1362-6
pubmed: 27016475
Trends Cardiovasc Med. 2020 Feb;30(2):115-122
pubmed: 31000325
Eur Heart J. 2009 Apr;30(8):940-9
pubmed: 19004844
Can J Cardiol. 2021 Feb;37(2):319-328
pubmed: 32387225
Eur Heart J. 2013 May;34(19):1396-403
pubmed: 23355652
J Cardiovasc Electrophysiol. 2019 Jul;30(7):1096-1101
pubmed: 31094058
Eur Heart J Cardiovasc Imaging. 2016 Mar;17(3):262-9
pubmed: 26588984
JACC Clin Electrophysiol. 2021 Feb;7(2):135-147
pubmed: 33602393
Europace. 2020 Jan 1;22(1):125-132
pubmed: 31746996
Int J Cardiol. 2016 Oct 15;221:597-600
pubmed: 27420585
J Cardiovasc Electrophysiol. 2020 Feb;31(2):485-493
pubmed: 31930753
Heart Rhythm. 2015 Jul;12(7):1548-57
pubmed: 25828601
Europace. 2017 Jan;19(1):103-109
pubmed: 26843575
JACC Heart Fail. 2015 Dec;3(12):990-7
pubmed: 26577619
JACC Clin Electrophysiol. 2020 Jul;6(7):849-858
pubmed: 32703568
JACC Cardiovasc Imaging. 2014 Oct;7(10):969-79
pubmed: 25240452
J Am Coll Cardiol. 2019 Dec 17;74(24):3039-3049
pubmed: 31865972
Europace. 2017 Feb 1;19(2):289-296
pubmed: 28175277
Europace. 2014 Sep;16(9):1342-9
pubmed: 24576973
JACC Clin Electrophysiol. 2021 Nov;7(11):1422-1432
pubmed: 34167929
J Cardiovasc Electrophysiol. 2020 Feb;31(2):560-569
pubmed: 31919928
ESC Heart Fail. 2020 Aug;7(4):1711-1722
pubmed: 32400967
J Cardiovasc Electrophysiol. 2014 Mar;25(3):283-92
pubmed: 24237881
Heart Rhythm. 2019 Dec;16(12):1783-1790
pubmed: 31513945
Am J Cardiol. 2009 Nov 15;104(10):1407-12
pubmed: 19892059
J Am Coll Cardiol. 2019 Jul 9;74(1):157-159
pubmed: 31078637

Auteurs

Margarida Pujol-López (M)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Rafael Jiménez Arjona (R)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.

Eduard Guasch (E)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Adelina Doltra (A)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

Roger Borràs (R)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain.

Ivo Roca Luque (I)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

María Ángeles Castel (MÁ)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Paz Garre (P)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.

Elisenda Ferró (E)

Medtronic Iberica, Barcelona, Spain.
Fundació Clínic per a la Recerca Biomèdica (FCRB), Barcelona, Catalonia, Spain.

Mireia Niebla (M)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.

Esther Carro (E)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.

Elena Arbelo (E)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Marta Sitges (M)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

José M Tolosana (JM)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Lluís Mont (L)

Institut Clínic Cardiovascular (ICCV), Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH